美国 · 股市与财经 · Investor's Business Daily

AbbVie Partner Flies Sky-High On News For Its $3 Billion Cancer Contender

来源：Investor's Business Daily · 美国 12 小时前

The addition of Genmab's Epkinly to a standard cocktail of drugs helped lymphoma patients live longer before worsening.

在 Investor's Business Daily 阅读全文登录后可收藏

MediaNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.investors.com)

推荐阅读

A.I. Officials Stonewall on Questions About Technology’s Risks

Solana Debuts Institutional Settlement Standard With J.P. Morgan Input

Trump says MAGA Inc. PAC will pay for controversial TV ads that government funded

Exclusive: OpenAI is piloting a ‘mission interview’ for job candidates

Business Insider

Elon Musk is a trillionaire again

Oil price floor likely rising to $70/bbl, ConocoPhillips chairman says